TSH Variability of Patients Affected by Differentiated Thyroid Cancer Treated with Levothyroxine Liquid Solution or Tablet Form
Background. Recent guidelines from the American Thyroid Association (ATA) indicate that, in many patients affected by differentiated thyroid cancer (DTC), the serum TSH should be maintained between 0.1 and 0.5 mU/L. The purpose of this study was to evaluate the TSH variability of patients affected b...
Saved in:
Main Authors: | Carlo Cappelli, Ilenia Pirola, Elena Gandossi, Claudio Casella, Davide Lombardi, Barbara Agosti, Fiorella Marini, Andrea Delbarba, Maurizio Castellano |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2017/7053959 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Could Serum TSH Levels Predict Malignancy in Euthyroid Patients Affected by Thyroid Nodules with Indeterminate Cytology?
by: Carlo Cappelli, et al.
Published: (2020-01-01) -
Liquid Levothyroxine Formulation Taken during Lunch in Italy: A Case Report and Review of the Literature
by: Carlo Cappelli, et al.
Published: (2020-01-01) -
Elastography Evaluation of Benign Thyroid Nodules in Patients Affected by Hashimoto’s Thyroiditis
by: Carlo Cappelli, et al.
Published: (2015-01-01) -
Changes in Serum TSH and T4 Levels after Switching the Levothyroxine Administration Time from before Breakfast to before Dinner
by: S. Ala, et al.
Published: (2015-01-01) -
A Case of Concurrent Riedel’s, Hashimoto’s and Acute Suppurative Thyroiditis
by: I. Pirola, et al.
Published: (2009-01-01)